Article
Preparing for Next-Generation Antimalarials in Nigeria: A Pre-Introduction Readiness Assessment with Focus on Infant-Friendly Formulations and Emerging Therapies
2026-03-25
Abstract excerpt
<title>Abstract</title> <p> <italic>Nigeria shoulders the world's highest national malaria burden, accounting for approximately 25.9% of global malaria cases and 30.9% of malaria deaths in 2023, with children under five years of age comprising the most vulnerable group. As the global antimalarial pipeline advances notably with GanLum (ganaplacide-lumefantrine), which completed successful Phase 3 trials in Novemb...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8bb1c23-755c-5f05-9306-309ef96ccf37
- DOI
- 10.21203/rs.3.rs-9201692/v1
